Drug Database
Back to search

Netherlands· NL-bb10d062bac7

Cholib 145 mg/40 mg filmomhulde tabletten

A simvastatin and fenofibrate product containing fenofibraat + simvastatine, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCholib 145 mg/40 mg filmomhulde table…ATCC10BA04REGISTER NO.NL-bb10d062bac7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fenofibraat + simvastatineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Simvastatin and fenofibrate is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA04 (simvastatin and fenofibrate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search simvastatin and fenofibrate products by name

Simvastatin and fenofibrate · ATC C10BA04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FENOFIBRAAT + SIMVASTATINE
Manufacturer
Viatris Healthcare Limited
Country
Netherlands (NL)
ATC code
C10BA04
ATC class
Simvastatin and fenofibrate
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/13/866

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for simvastatin and fenofibrate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check simvastatin and fenofibrate against other medicinesHow interaction checks work

Simvastatin and fenofibrate · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Simvastatin and fenofibrate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatin and fenofibrate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cholib
  • Liechtenstein · Cholib
  • Norway · Cholib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f478f097-2205-4d86-81df-1ea54ec8833d
GET /v1/drugs/f478f097-2205-4d86-81df-1ea54ec8833d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cholib-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Simvastatin and fenofibrate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp111437",
  "excipients": [
    "ASCORBINEZUUR (E 300)",
    "BUTYLHYDROXYANISOL (E 320)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CITROENZUUR 1-WATER (E 330)",
    "CROSPOVIDON (E 1202)",
    "DOCUSAATNATRIUM",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "LECITHINE, SOYA (E 322)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "SACCHAROSE",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "XANTHAANGOM (E 415)"
  ],
  "substances": [
    "FENOFIBRAAT",
    "SIMVASTATINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2013/08/26",
  "procedure_number": "EMEA/H/C/002559",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/13/866",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about simvastatin and fenofibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console